Journal of Veterinary and Animal Sciences

Volume: 55 Issue: 1

  • Open Access
  • Research Article

Histopathological and immunophenotypical classification of canine mammary tumours

Nisna Niyas1, I. S. Sajitha1*, K.S. Prasanna1, S. S. Devi1, Sudheesh S Nair2, A.K. Anseena1 and S. Afsal3

1. Department of Veterinary Pathology

2. Department of Veterinary Surgery and Radiology

College of Veterinary and Animal Science, Mannuthy, Thrissur - 680 651 Kerala Veterinary and Animal Sciences University Kerala, India

3. Animal Husbandry Department   

*Corresponding author: [email protected], Ph. 9446193407

Year: 2024, Page: 122-128, Doi: https://doi.org/10.51966/jvas.2024.55.1.122-128

Received: Oct. 10, 2023 Accepted: Dec. 12, 2023 Published: March 31, 2024

Abstract

Canine mammary tumour (CMT) is the most common malignancy reported in intact female dogs. The present study is envisaged to classify the CMTs based on the histopathologic type, grade and hormone receptor status. Twenty-five cases of CMTs were taken as the study material. The excisional biopsy samples from all the cases were collected and processed for histopathology and grading of tumours. The immunohistochemical evaluation of oestrogen receptor (ER) and/or progesterone receptor (PR) or human epidermal growth factor type II receptor (HER2) in CMTs was carried out to classify them. Luminal A had the highest number of cases followed by luminal B. One case of triple negative breast cancer (TNBC) and two cases of HER2 enriched tumours were also noted. All the tumours in HER2 enriched and TNBC were grade 3 with aggressive characters like lymphatic invasion and angiogenesis. The prognosis of the above cases was studied and the data revealed poor prognosis in the HER2 enriched and TNBC compared to luminal A and B. The implementation of targeted therapy in canine mammary tumours based on hormone receptor status may increase the chances of recovery or may prolong the survival period in canine patients.

Keywords: Canine mammary tumours, ER, PR, HER2, TNBC

References

Chang, C.C., Tsai, M.H., Liao, J.W., Chan, J.P.W., Wong, M.L. and Chang, S.C., 2009. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumours. J. Am. Vet. Med. Assoc. 235: 391-396.

Clemente, M., Perez-Alenza, M.D., Illera, J.C. and Pena, L. 2010.Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Vet. Pathol.47: 265-274.

Devi, S.S., George, A.J., Dhanushkrishna, B., Prasanna, K.S., Radhika, G. and John Martin, K.D. 2022. Histomorphological stratification of stromal types associated with canine mammary tumour. J. Vet. Anim. Sci53(4): 688-693.

Dutra, A.P., Granja, N.V.M., Schmitt, F.C. and Cassali, G.D. 2004. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz. J. Med. Biol. Res. 37: 1673-1681.

Ellis, M.J., Tao, Y., Luo, J., A'hern, R., Evans, D.B., Bhatnagar, A.S., Chaudri Ross, H.A., Von Kameke, A., Miller, W.R., Smith, I. and Eiermann, W., 2008. Outcome prediction for estrogen receptor–positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst. 100:1380-1388.

Geraldes, M., Gärtner, F. and Schmitt, F., 2000. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet. Rec. 146: 403-406.

Gray, M., Meehan, J., Martínez-Pérez, C., Kay, C., Turnbull, A.K., Morrison, L.R., Pang, L.Y. and Argyle, D., 2020. Naturally-occurring canine mammary tumors as a translational model for human breast cancer. Front. Oncol10: 617.

Kim, N.H., Lim, H.Y., Im, K.S., Kim, J.H. and Sur, J.H. 2013. Identification of triple negative and basal-like canine mammary carcinomas using four basal markers. J. Comp. Pathol. 148: 298-306.

Muhammadnejad, A., Keyhani, E., Mortazavi, P., Behjati, F. and Haghdoost, I.S., 2012. Overexpression of her-2/neu in malignant mammary tumors; translation of clinicopathological features from dog to human. Asian Pac J Cancer Prev. 12: 6415-21

Pena, L., Gama, A., Goldschmidt, M.H., Abadie, J., Benazzi, C., Castagnaro, M., Díez, L., Gärtner, F., Hellmén, E., Kiupel, M. and Millán, Y. 2014. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry. Vet. Pathol. 51: 127-145.

Ramos-Vara, J.A. 2005.Technical aspects of immunohistochemistry. Vet. Pathol.42: 405-426.

Rutteman, G.R., Misdorp, W., Blankenstein, M.A. and Van den Brom, W.E. 1988. Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. Br. J. Can. 58: 594-599.

Spencer, L.T. and Bancroft, J.D. 2013. Tissue processing. In Bancroft, J. D., Layton, C. and Suvarna, S.K.(eds), Theory and Practice of Histological Techniques.(7th Ed.). Churchill Livingstone, Edinburgh, pp. 114-123.

Suvarna, K., Layton, C. and Bancroft, J. D. 2018. Bancroft’s Theory and Practice of Histological Techniques. (8th Ed.). Elsevier Health Sciences, Churchill, 584p.

Thuroczy, J., Reisvaag, G.J.K., Perge, E., Tibold, A., Szilágyi, J. and Balogh, L., 2007. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. J. Comp. Pathol. 137: 122-129.

Tsang, J.Y. and Gary, M.T., 2020. Molecular classification of breast cancer. Adv Anat Pathol. 27:27-35.

Cite this article

Niyas N., Sajitha I.S., Prasanna K.S., Devi S.S., Nair S.S., AnseenaA.K. and Afsal S. 2024. Histopathological and immunophenotypical classification of canine mammary tumours. J. Vet. Anim. Sci. 55(1):122-128

DOI: https://doi.org/10.51966/jvas.2024.55.1.122-128

Views
89
Downloads
42
Citations